{"count":220324,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2084","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2082","results":[{"created":"2019-11-28T09:56:48.672736+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.5","user_name":"Chirag Patel","item_type":"entity","text":"Source KidGen_Amyloidosis v38.1.0 was removed from APOA1.\nSource Expert list was added to APOA1.\nMode of inheritance for gene APOA1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: APOA1 were changed from  to Amyloidosis, 3 or more types\nPublications for gene APOA1 were changed from PubMed:31482740; 29968409; 27240838 to PubMed:31482740; 29968409; 27240838","entity_name":"APOA1","entity_type":"gene"},{"created":"2019-11-28T09:56:24.653507+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.4","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: APOA1: Rating: GREEN; Mode of pathogenicity: None; Publications: PubMed:31482740, 29968409, 27240838; Phenotypes: Amyloidosis, 3 or more types; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"APOA1","entity_type":"gene"},{"created":"2019-11-28T09:52:51.541751+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.4","user_name":"Chirag Patel","item_type":"entity","text":"edited their review of gene: FGA: Changed rating: GREEN; Changed publications: PubMed: 8097946, 8639778, 12050338","entity_name":"FGA","entity_type":"gene"},{"created":"2019-11-28T09:52:45.368123+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.4","user_name":"Chirag Patel","item_type":"entity","text":"Source KidGen_Amyloidosis v38.1.0 was removed from FGA.\nSource Expert list was added to FGA.\nMode of inheritance for gene FGA was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: FGA were changed from  to Amyloidosis, familial visceral\nPublications for gene FGA were changed from PubMed: 8097946; 8639778; 12050338 to PubMed: 8097946; 8639778; 12050338","entity_name":"FGA","entity_type":"gene"},{"created":"2019-11-28T09:50:41.405370+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.3","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: FGA: Rating: ; Mode of pathogenicity: None; Publications: ; Phenotypes: Amyloidosis, familial visceral; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"FGA","entity_type":"gene"},{"created":"2019-11-28T09:50:18.914441+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.3","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: LYZ: Rating: GREEN; Mode of pathogenicity: None; Publications: PubMed: 1808634, 8464497, 15745733,; Phenotypes: Amyloidosis, renal; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"LYZ","entity_type":"gene"},{"created":"2019-11-28T09:50:00.335150+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.3","user_name":"Chirag Patel","item_type":"entity","text":"Source KidGen_Amyloidosis v38.1.0 was removed from LYZ.\nSource Expert list was added to LYZ.\nMode of inheritance for gene LYZ was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: LYZ were changed from  to Amyloidosis, renal\nPublications for gene LYZ were changed from PubMed: 1808634; 8464497; 15745733, to PubMed: 1808634; 8464497; 15745733,","entity_name":"LYZ","entity_type":"gene"},{"created":"2019-11-28T09:47:12.162474+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.2","user_name":"Chirag Patel","item_type":"entity","text":"Publications for gene NLRP3 were changed from PubMed: 11687797; 28229991; 27435956; 31057541 to PubMed: 11687797; 28229991; 27435956; 31057541","entity_name":"NLRP3","entity_type":"gene"},{"created":"2019-11-28T09:47:01.117623+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.1","user_name":"Chirag Patel","item_type":"entity","text":"Source KidGen_Amyloidosis v38.1.0 was removed from NLRP3.\nSource Expert list was added to NLRP3.\nMode of inheritance for gene NLRP3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPhenotypes for gene: NLRP3 were changed from  to Muckle-Wells syndrome","entity_name":"NLRP3","entity_type":"gene"},{"created":"2019-11-28T09:45:49.695922+11:00","panel_name":"Amyloidosis_KidGen","panel_id":191,"panel_version":"0.0","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: NLRP3: Rating: GREEN; Mode of pathogenicity: None; Publications: PubMed: 11687797, 28229991, 27435956, 31057541; Phenotypes: Muckle-Wells syndrome; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NLRP3","entity_type":"gene"},{"created":"2019-11-28T07:56:50.856006+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CNTN4 as ready","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:56:50.848625+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntn4 has been classified as Red List (Low Evidence).","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:56:40.373266+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CNTN4 as Red List (low evidence)","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:56:40.359975+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntn4 has been classified as Red List (Low Evidence).","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:54:43.041958+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CNTN4 as ready","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:54:43.033070+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntn4 has been classified as Red List (Low Evidence).","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:54:39.279801+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CNTN4 as Red List (low evidence)","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:54:39.272095+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntn4 has been classified as Red List (Low Evidence).","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:53:54.455530+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CNTN4 were changed from  to Intellectual disability; SCA","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:53:32.587750+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CNTN4 were set to ","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:53:16.543914+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CNTN4 as Red List (low evidence)","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:53:16.505674+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cntn4 has been classified as Red List (Low Evidence).","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:52:50.180917+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CNTN4 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:52:13.816226+11:00","panel_name":"Autism_VCGS","panel_id":51,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CNTN4: Rating: RED; Mode of pathogenicity: None; Publications: 15106122, 18349135, 17932120; Phenotypes: Intellectual disability, SCA; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-28T07:49:07.488919+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CNTN4: Rating: RED; Mode of pathogenicity: None; Publications: 15106122, 18349135, 17932120; Phenotypes: Intellectual disability, SCA; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CNTN4","entity_type":"gene"},{"created":"2019-11-27T21:08:44.989150+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CLIP2: Rating: RED; Mode of pathogenicity: None; Publications: 22608712; Phenotypes: Intellectual disability; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CLIP2","entity_type":"gene"},{"created":"2019-11-27T21:01:15.335465+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CLCNKB: Rating: GREEN; Mode of pathogenicity: None; Publications: 18310267, 29254190; Phenotypes: Bartter syndrome, type 3, MIM#607364, Bartter syndrome, type 4b, digenic, MIM#613090; Mode of inheritance: Other","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2019-11-27T18:41:52.383933+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CLCNKA: Rating: GREEN; Mode of pathogenicity: None; Publications: 18310267, 29254190; Phenotypes: Bartter syndrome, type 4b, digenic, MIM#613090; Mode of inheritance: Other","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2019-11-27T14:07:22.067685+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CLCN2: Rating: AMBER; Mode of pathogenicity: None; Publications: 23707145; Phenotypes: Leukoencephalopathy with ataxia, MIM#615651; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-11-27T14:03:26.964004+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CISD2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Wolfram syndrome 2, MIM#604928; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-11-27T14:00:52.923779+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CHST14: Rating: AMBER; Mode of pathogenicity: None; Publications: 25703627; Phenotypes: Ehlers-Danlos syndrome, musculocontractural type 1, MIM#601776; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-11-27T12:34:47.401129+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CHD3 was added\ngene: CHD3 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: CHD3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: CHD3 were set to 30397230\nPhenotypes for gene: CHD3 were set to Snijders Blok-Campeau syndrome, MIM#618205\nReview for gene: CHD3 was set to GREEN\ngene: CHD3 was marked as current diagnostic\nAdded comment: 35 individuals from 33 unrelated families reported with heterozygous variants in this gene. \nSources: Expert list","entity_name":"CHD3","entity_type":"gene"},{"created":"2019-11-27T12:25:37.580801+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CHD1 was added\ngene: CHD1 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Literature\nMode of inheritance for gene: CHD1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: CHD1 were set to 28866611\nPhenotypes for gene: CHD1 were set to Pilarowski-Bjornsson syndrome, MIM#617682\nReview for gene: CHD1 was set to GREEN\nAdded comment: Six unrelated individuals with heterozygous variants reported. \nSources: Literature","entity_name":"CHD1","entity_type":"gene"},{"created":"2019-11-27T12:19:52.140079+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR3: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Hemolytic uremic syndrome, atypical, susceptibility to, MIM#235400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR3","entity_type":"gene"},{"created":"2019-11-27T12:12:34.602742+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Hemolytic uremic syndrome, atypical, susceptibility to, MIM#235400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR1","entity_type":"gene"},{"created":"2019-11-27T12:07:07.813664+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFH: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Complement factor H deficiency, MIM#609814; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFH","entity_type":"gene"},{"created":"2019-11-27T08:43:25.705868+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEP89 as ready","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:43:25.695854+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep89 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:43:22.473369+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEP89 were changed from  to Mitochondrial complex IV deficiency","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:43:02.540454+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEP89 were set to ","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:42:37.926226+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEP89 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:42:05.035455+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CEP89 as Amber List (moderate evidence)","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:42:04.999301+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep89 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:41:38.213396+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEP89: Rating: AMBER; Mode of pathogenicity: None; Publications: 23575228; Phenotypes: Mitochondrial complex IV deficiency; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T08:40:53.759299+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEP89: Rating: AMBER; Mode of pathogenicity: None; Publications: 23575228; Phenotypes: Mitochondrial complex IV deficiency; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP89","entity_type":"gene"},{"created":"2019-11-27T07:50:57.556759+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEP63 as ready","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:50:57.548140+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:50:53.935285+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEP63 were changed from  to Seckel syndrome 6, MIM#614728","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:50:33.748731+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.12","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEP63 were set to ","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:50:12.545871+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.11","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEP63 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:49:46.332031+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CEP63 as Amber List (moderate evidence)","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:49:46.322312+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:49:09.393427+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEP63 as ready","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:49:09.386390+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:49:00.727572+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEP63 were changed from  to Seckel syndrome 6, MIM#614728","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:48:36.397963+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEP63 were set to ","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:48:13.068394+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEP63 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:47:54.958981+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CEP63 as Amber List (moderate evidence)","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:47:54.950513+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:45:22.095692+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEP63 as ready","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:45:22.087456+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:45:18.435603+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEP63 were changed from  to Seckel syndrome 6, MIM#614728","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:45:01.671765+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEP63 were set to 21983783; 26158450","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:44:45.246491+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEP63 were set to ","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:44:10.348047+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEP63 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:43:43.895413+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CEP63 as Amber List (moderate evidence)","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:43:43.877824+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cep63 has been classified as Amber List (Moderate Evidence).","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:43:13.680472+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEP63: Rating: AMBER; Mode of pathogenicity: None; Publications: 21983783, 26158450; Phenotypes: Seckel syndrome 6, MIM#614728; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:41:58.831435+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEP63: Rating: AMBER; Mode of pathogenicity: None; Publications: 21983783, 26158450; Phenotypes: Seckel syndrome 6, MIM#614728; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CEP63","entity_type":"gene"},{"created":"2019-11-27T07:35:21.343500+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDT1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Meier-Gorlin syndrome 4, MIM#613804; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CDT1","entity_type":"gene"},{"created":"2019-11-26T21:02:30.656738+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KIF1BP as ready","entity_name":"KIF1BP","entity_type":"gene"},{"created":"2019-11-26T21:02:30.649493+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kif1bp has been classified as Green List (High Evidence).","entity_name":"KIF1BP","entity_type":"gene"},{"created":"2019-11-26T21:02:25.118528+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KIF1BP as Green List (high evidence)","entity_name":"KIF1BP","entity_type":"gene"},{"created":"2019-11-26T21:02:25.110172+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kif1bp has been classified as Green List (High Evidence).","entity_name":"KIF1BP","entity_type":"gene"},{"created":"2019-11-26T21:02:10.741730+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"gene: KIF1BP was added\ngene: KIF1BP was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: KIF1BP was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: KIF1BP were set to Goldberg-Shprintzen megacolon syndrome\t609460\nReview for gene: KIF1BP was set to GREEN\nAdded comment: Sources: Expert list","entity_name":"KIF1BP","entity_type":"gene"},{"created":"2019-11-26T20:55:57.906702+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDK6 as ready","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:55:57.899530+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk6 has been classified as Amber List (Moderate Evidence).","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:55:50.219354+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDK6 were changed from  to Microcephaly 12, primary, autosomal recessive, MIM#616080","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:55:26.220314+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CDK6 were set to ","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:55:03.855961+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.95","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDK6 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:54:45.296680+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.94","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDK6 as Amber List (moderate evidence)","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:54:45.287101+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.94","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk6 has been classified as Amber List (Moderate Evidence).","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:52:40.438894+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDK6 as ready","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:52:40.431135+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk6 has been classified as Amber List (Moderate Evidence).","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:52:36.980950+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDK6 were changed from  to Microcephaly 12, primary, autosomal recessive, MIM#616080","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:52:14.156422+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CDK6 were set to ","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:51:42.370929+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDK6 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:51:17.384699+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDK6 as Amber List (moderate evidence)","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:51:17.366578+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk6 has been classified as Amber List (Moderate Evidence).","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:50:43.973314+11:00","panel_name":"Microcephaly_VCGS","panel_id":138,"panel_version":"0.1","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDK6: Rating: AMBER; Mode of pathogenicity: None; Publications: 23918663; Phenotypes: Microcephaly 12, primary, autosomal recessive, MIM#616080; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:49:59.281056+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDK6: Rating: AMBER; Mode of pathogenicity: None; Publications: 23918663; Phenotypes: Microcephaly 12, primary, autosomal recessive, MIM#616080; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CDK6","entity_type":"gene"},{"created":"2019-11-26T20:43:42.431872+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDK16: Rating: AMBER; Mode of pathogenicity: None; Publications: 25644381; Phenotypes: Intellectual disability; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"CDK16","entity_type":"gene"},{"created":"2019-11-26T20:38:39.693275+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.92","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CD96 as ready","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:38:39.686066+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.92","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd96 has been classified as Amber List (Moderate Evidence).","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:38:31.561188+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.92","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CD96 were changed from  to C syndrome, MIM#211750","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:38:05.267282+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.91","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CD96 were set to ","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:37:40.427678+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CD96 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:37:21.584206+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CD96 as Amber List (moderate evidence)","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:37:21.576175+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd96 has been classified as Amber List (Moderate Evidence).","entity_name":"CD96","entity_type":"gene"},{"created":"2019-11-26T20:35:17.766178+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CD96 as ready","entity_name":"CD96","entity_type":"gene"}]}